Santarus, Inc. Q4 2009 Earnings Call TranscriptSeeking Alpha (blog)GSK also has committed a clinical trial application in China, which is similar to an IND application in the US, and plans to initiate clinical studies there ...and more »

TopNews United StatesGlaxoSmithKline Pharmaceuticals Limited Response to Recent Media Reports on ...Business Wire India (press release)Dr. A Ramachandran- Chairman, Dr. A. Ramachandran's Diabetes Hospital and President- India Diabetes Research Foundation, said, “Rosiglitazone is a very ...GSK salvages diabetes drug, for nowDaily News & Analysisall 211 news articles »

GSK salvages diabetes drug, for nowDaily News & AnalysisAccording to a spokesperson from GSK Plc, the company has acted responsibly in conducting its clinical trial programme for rosiglitazone, in marketing the ...and more »

GSK: Committed to improving UK clinical researchPharmafocusDr Pim Kon, medical director for GSK UK, talks about efforts to halt the decline in clinical research in the UK, Nicola O'Brien reports. ...

Large, Long-term Study Shows GSK's Rosiglitazone has no Increased ...Business Wire India (press release), IndiaThis data is very relevant in the Indian context, given that India has over 42 million diabetics and every fifth diabetic in the world is a native Asian Indian” said Dr. Sadhna Joglekar, GlaxoSmithKline's VP Medical, Regulatory & Clinical Research, ...

Knowledge@WhartonGlaxoSmithKline's Hasit Joshipura: Seeing a Healthy Future for ...Knowledge@Wharton, PAGSK's years of experience in India may soon pay significant dividends, Joshipura suggests: The company has developed low-cost manufacturing sites for selling internally and for export, set up a clinical trials network, and tapped local know-how in R&D. ...

Company and People Notes: GSK Acquires Stiefel Laboratories; Roche ...Pharmaceutical Technology Magazine, NJChiltern International (London), a clinical research organization (CRO) providing services in Europe, the Americas and India, announced the acquisition of Vigiun, a CRO located in Sao Paulo, Brazil. Vigiun's founders, Eduardo Forleo and Elisa Halker, ...

Cipla opposes patent for GSK’s cancer drugEconomic Times, IndiaAccording to a report by Research and Markets, cancer vaccines are expected to record the fastest growth rate between 2007 and 2012. Drugs for cancer represent the largest therapy area under clinical development with drug manufactures now focused on ...

‘Productivity of global pharma R&D pipelines has fallen’Economic Times, India - 4 hours agoIt is not necessarily linked to GSK India. GSK Plc independently has been a doing a lot in the country. We do a lot of clinical trials which have been ...

Ranbaxy, GSK in JV for initiate phase I trialBusiness Standard, India - 1 hour agoRanbaxy Laboratories has initiated phase I clinical trial of a lead compound for respiratory inflammation, a company release said today. ...Ranbaxy, GSK drug starts initial-stage trials Reuters IndiaRanbaxy's NDDR team achieves landmark in GSK research prog Moneycontrol.comRanbaxy Lab in poor health Moneycontrol.comall 7 news articles